1.
入组病人基本人口学和临床资料
Baseline demographics and clinical characteristics of patients
| Gender | Age (year) |
Efficacy | Chemotherapy regimen/ cycles |
Chemotherapy PFS (month) |
Tarceva PFS (month) |
Vandetanib PFS (month) | OS (month) |
|
| PFS: progression free survival; OS: overall survival; SD: stable disease; PD: progressive disease. | ||||||||
| 1 | Female | 34 | SD | GP1, NP1 | 15 | 22 | 7.5 | Following |
| 2 | Female | 48 | SD | DC1, GC3 | 9 | 14 | 11 | 24 |
| 3 | Male | 45 | PD | GC4 | 4 | 10 | 1.5 | 28 |
| 4 | Male | 26 | PD | GC4 | 5 | 2 | 2 | 16 |
| 5 | Female | 61 | PD | TC2 | 1.5 | 1 | 0.5 | 5 |